Literature DB >> 23707077

Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.

Yi Yongjun1, Huang Shuyun, Chen Lei, Chen Xiangrong, Yang Zhilin, Ke Yiquan.   

Abstract

Microglia, the immune cells of the brain, often present in large numbers in gliomas, where they promote tumor growth and invasiveness. This study found that atorvastatin reduced the pro-tumorigenic effects of microglia on glioma migration and invasion by reducing the microglial expression of membrane type 1 metalloproteinase (MT1-MMP). The results suggest that down-regulation of MT1-MMP is controlled by a p38 MAPK pathway in microglia. Taken together, the results support further research on atorvastatin as a candidate for glioma therapy by targeting microglia.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707077     DOI: 10.1016/j.jneuroim.2013.04.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Authors:  Hannah M Jones; Ziwei Fang; Wenchuan Sun; Leslie H Clark; Jessica E Stine; Arthur-Quan Tran; Stephanie A Sullivan; Timothy P Gilliam; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.

Authors:  Karen A Oliveira; Tharine Dal-Cim; Flávia G Lopes; Fabiana K Ludka; Cláudia B Nedel; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

3.  Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

Authors:  Caroline Happold; Thierry Gorlia; L Burt Nabors; Sara C Erridge; David A Reardon; Christine Hicking; Martin Picard; Roger Stupp; Michael Weller
Journal:  J Neurooncol       Date:  2018-02-08       Impact factor: 4.130

Review 4.  Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

Authors:  Dayle Rundle-Thiele; Richard Head; Leah Cosgrove; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

5.  Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.

Authors:  Luis F Rendon; Ishaan A Tewarie; David J Cote; Aaron Gabriel; Timothy R Smith; Marike L D Broekman; Rania A Mekary
Journal:  Drugs       Date:  2022-02-05       Impact factor: 9.546

Review 6.  Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease.

Authors:  Xi-Bin Zhou; Yu-Xing Zhang; Chun-Xiang Zhou; Jun-Jie Ma
Journal:  Chin J Integr Med       Date:  2021-11-03       Impact factor: 1.978

Review 7.  Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Authors:  Amandeep Thakur; Chetna Faujdar; Ram Sharma; Sachin Sharma; Basant Malik; Kunal Nepali; Jing Ping Liou
Journal:  J Med Chem       Date:  2022-07-05       Impact factor: 8.039

8.  [Atorvastatin inhibits malignant behaviors and induces apoptosis in human glioma cells by up-regulating miR-146a and inhibiting the PI3K/Akt signaling pathway].

Authors:  Y Cui; S Fan; D Pan; Q Chao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

9.  Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.

Authors:  Monica N Schointuch; Timothy P Gilliam; Jessica E Stine; Xiaoyun Han; Chunxiao Zhou; Paola A Gehrig; Kenneth Kim; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2014-05-28       Impact factor: 5.482

Review 10.  Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.

Authors:  Hisham F Bahmad; Darine Daher; Abed A Aljamal; Mohamad K Elajami; Kei Shing Oh; Juan Carlos Alvarez Moreno; Ruben Delgado; Richard Suarez; Ana Zaldivar; Roshanak Azimi; Amilcar Castellano; Robert Sackstein; Robert J Poppiti
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.